La Jolla Pharmaceutical: prpimary binding site found for blood clotting condition
Article Abstract:
La Jolla Pharmaceutical Co. reported its discovery of the binding region for antibodies thought to cause a condition known as the Antiphospholipid Syndrome (APS).
Publication Name: Genesis Report-Dx
Subject: Health care industry
ISSN: 1061-2289
Year: 1999
User Contributions:
Comment about this article or add new information about this topic:
What's in my genome array?
Article Abstract:
Understanding of genetic factors underlying complex biological functions is the true benefit of solving the human genome project.
Publication Name: Genesis Report-Dx
Subject: Health care industry
ISSN: 1061-2289
Year: 2001
User Contributions:
Comment about this article or add new information about this topic:
Biochips and DNA chips- the camel's nose is under the tent
Article Abstract:
Santa Clara, CA-based Affymetrix pioneered DNA chip technology. The company has accumulated a number of patents.
Publication Name: Genesis Report-Dx
Subject: Health care industry
ISSN: 1061-2289
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: A new collaborative practice: critical care and hematology/oncology - altering the misconceptions. Hematologic emergencies in the intensive care unit
- Abstracts: Managed care positives and negatives for health care marketing. Promotional Model: A New Direction for the National Programme on Immunization (NPI) and Oral Rehydration Therapy (ORT) in Nigeria
- Abstracts: Preterm birth in the United States: current issues and future perspectives
- Abstracts: Risk adjustment for the Medicare program: lessons learned from research and demonstrations. The cost effectiveness of post-acute care for elderly Medicare beneficiaries
- Abstracts: Antibacterials - Competitive Business Activity by Indication. Pharmaceutical management of hypertension-platform strategies and innovative activity